Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy

Published:2012-06-12 Issue:6 Volume:7 Page:e38072
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Bochove Kees,van Schalkwijk Daniël B.,Parnell Laurence D.,Lai Chao-Qiang,Ordovás José M.,de Graaf Albert A.,van Ommen Ben,Arnett Donna K.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Fibrates: No ACCORD on their use in the treatment of dyslipidaemia.;AS Wierzbicki;Curr Opin Lipidol,2010

2. Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective.;M Elam;Curr Opin Lipidol,2011

3. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: A systematic review and meta-analysis.;E Bruckert;J Cardiovasc Pharmacol,2011

4. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.;Br Heart J,1978

5. Clofibrate and Niacin in Coronary Heart Disease.;JAMA,1975

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study;Scientific Reports;2023-12-19

2. Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes;Genes & Nutrition;2023-03-10

3. Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety;Personalized Medicine;2022-11-23

4. Optimized Metabotype Definition Based on a Limited Number of Standard Clinical Parameters in the Population-Based KORA Study;Life;2022-09-20

5. Personalized medicine in lipid-modifying therapy;Personalized Medicine;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3